Issue 1389: October 10, 2018
TOP STORIES
IAC HANDOUTS
VACCINE INFORMATION STATEMENTS
WORLD NEWS
FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS
EDUCATION AND TRAINING
CONFERENCES AND MEETINGS
TOP STORIES
FDA announces approval of expanded use of Gardasil 9 to include adults 27 through 45 years old
In an October 5 news release, the U.S. Food and Drug Administration (FDA) announced it has approved the expanded use of Gardasil 9 (human papillomavirus [HPV] 9-valent recombinant vaccine; Merck) for individuals ages 27 through 45 years of age. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.
A statement by Peter Marks, MD, PhD, director of the FDA's Center for Biologics Evaluation and Research, included in the news release, is reprinted below.
Today’s approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range. The Centers for Disease Control and Prevention has stated that HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing.
View the complete October 5 press release on the FDA website: FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old.
Related Links
Back to top
IAC updates two of its popular Ask the Experts sections: one on vaccine administration and the second on vaccine storage and handling
IAC's Ask the Experts: Administering Vaccines and Ask the Experts: Storage and Handling web pages have been completely reviewed and updated by experts at CDC.
Ask the Experts: Administering Vaccines: Revisions were made to reorganize the web page, to update several website links and references, and to delete outdated information. Revisions were also made to disease burden.
Ask the Experts: Storage and Handling: Revisions include updates of website links, removal of references to obsolete products, and change in display of temperature ranges to be consistent with CDC standard (listing Celsius first with Fahrenheit values in parentheses). There are no new recommendations.
IAC’s Ask the Experts web section is a compilation of common as well as challenging questions and answers (Q&As) about vaccines and their administration. William Atkinson, MD, MPH, IAC's associate director for immunization education, manages this web section, with answers provided by Andrew T. Kroger, MD, MPH; Candice L. Robinson, MD, MPH; Raymond A. Strikas, MD, MPH, FACP, FIDSA; Tina S. Objio, MSN, MHA, RN; and JoEllen Wolicki, BSN, RN, all from the National Center for Immunization and Respiratory Diseases, CDC.
IAC Express publishes five special editions each year of Ask the Experts Q&As answered by CDC experts. You can access the four most recent IAC Express Ask the Experts sets of Q&As from the main web page of Ask the Experts, in the right-hand column.
Related Links
Back to top
IAC Spotlight! IAC’s Standing Orders Templates for Administering Vaccines web page contains standing orders templates and related resources that can help healthcare settings improve vaccination rates for patients of all ages
IAC's Standing Orders Templates for Administering Vaccines web page on immunize.org contains standing order templates and related resources for vaccines recommended for children, teens, and adults. Use the templates "as is" or modify them to suit your healthcare setting's needs.
Using standing order templates can help you improve vaccination rates. Standing orders authorize nurses, pharmacists, and other appropriately trained healthcare personnel, where allowed by state law, to assess a patient’s immunization status and administer vaccinations according to a protocol approved by a physician, medical director, or other authorized practitioner. Standing orders work by enabling assessment and vaccination of the patient without the need for clinician examination or direct order from the attending provider at the time of the interaction.
IAC has developed 31 standing orders templates for vaccines that are routinely recommended for children and adults. They are updated as needed and reviewed for technical accuracy by immunization experts at CDC. The most current versions can be accessed by going to www.immunize.org/standing-orders.
Visit the Standing Orders Templates for Administering Vaccines web page on immunize.org to access these valuable templates and resources.
Related Links
Back to top
CDC releases Digital Media Toolkit for the 2018–19 flu season to assist partners in communicating about the importance of vaccination
CDC has posted its 2018–19 Digital Campaign Toolkit with seasonal flu vaccination campaign materials to assist partners in communicating about the importance of vaccination. This digital toolkit includes a listing of events and activities, sample social media and newsletter content, graphics, web resources, web assets, and media preparation material. This material is downloadable and shareable, and some of the material is customizable. The full campaign toolkit can be viewed and downloaded in Spanish by choosing "Spanish" in the language bar in the top right corner of the page.
Visit CDC's 2018–19 Digital Campaign Toolkit web section to access the full range of resources it offers.
Related Links
Back to top
Just launched! "The 16 Vaccine" educational awareness website advocating CDC’s recommended second dose of MenACWY vaccine at age 16
The National Meningitis Association (NMA), in collaboration with Sanofi Pasteur, recently announced the launch of "The 16 Vaccine" educational awareness campaign website.
"The 16 Vaccine" website (https://the16vaccine.org) includes three brief, moving video stories—two told by meningitis survivors—a high school senior and a college junior—and another told by the sister of a teen-age girl who died from the disease. "The 16 Vaccine" website also offers social media resources that can be shared with personal and professional networks to educate parents about the dangers of bacterial meningitis.
This campaign advocates for CDC’s recommended second dose of MenACWY vaccine at age 16, when teens are most at risk for meningococcal meningitis. NMA also urges parents to discuss with their teen's doctor about all vaccinations they should consider for their teen.
Related Links
Back to top
Available online: six-part series of online training sessions on implementing standing orders protocols for adult immunization in your healthcare setting
Standing orders protocols (SOPs) are known to improve immunization coverage rates, but are underutilized by providers serving adult patients. The content for a six-part webinar series will help healthcare settings implement SOPs for adult immunizations.
The Executive Summary, provided by IAC executive director Dr. Deborah Wexler, gives a concise overview of the entire series presented by Drs. William Atkinson and Litjen Tan. Attending this series does not earn Continuing Education (CE) credit. The series is developed and provided by IAC, IDCareLive, and Pfizer.
Registration is free, but is required in order to view any session. The link will bring up a short registration form to create a free IDCareLive account, if you don’t already have one. After signing up, you will be transferred directly to the intended page.
Related Links
Back to top
IAC HANDOUTS
IAC updates "How to Administer Intramuscular and Intranasal Influenza Vaccines" to remove intradermal vaccine
IAC recently revised its resource for healthcare professionals titled How to Administer Intramuscular and Intranasal Influenza Vaccines. The instructions for administering the intradermal administration of influenza vaccine were removed because Fluzone ID (Sanofi) is no longer available.
Related Link
IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely.
Back to top
IAC posts updated 6-page handout for the public titled "Influenza: Questions and Answers"
IAC recently revised its 6-page handout for the public titled Influenza: Questions and Answers. Changes were made to update morbidity and mortality information for influenza, to separate out the recombinant influenza vaccine from other inactivated vaccines, to clarify the recommendation for the number of doses to give to children ages 6 months through 8 years for their primary vaccination, to expand and name the three brands of vaccine that can be given to infants beginning at age 6 months, and to include live attenuated influenza vaccine among the recommended vaccine products that can be given for the 2018–19 season.
Related Links
Back to top
VACCINE INFORMATION STATEMENTS
IAC posts updated Spanish translations of VISs for DTaP and MenACWY vaccines
IAC recently posted updated Spanish translations of the VISs for DTaP (diphtheria, tetanus, pertussis) and meningococcal ACWY vaccines. As reported in IAC Express on August 29, the English-language versions were updated on August 24, 2018.
IAC also posted the Spanish version of the DTaP and MenACWY VISs in rich text format (RTF). RTF files are intended for use in electronic systems, such as electronic medical records, immunization information systems, or other electronic databases. CDC supplies RTF files of the English-language VISs, and IAC provides Spanish RTF files of VISs for each routinely recommended vaccine.
Related Links
Back to top
WORLD NEWS
WHO supports Zimbabwe in effort to vaccinate 1.4 million people against cholera as outbreak spreads
The World Health Organization (WHO) is supporting Zimbabwe's effort to vaccinate 1.4 million people against cholera in the current outbreak by providing medical supplies and assistance with the rollout strategy. The outbreak, which began in the capital of Harare in early September, has led to over 8,535 suspected cases and 50 deaths, and it has spread to five additional districts.
Related Links
Back to top
FEATURED RESOURCES
IAC's 142-page book, Vaccinating Adults: A Step-by-Step Guide, describes how to implement adult vaccination services in your healthcare setting and provides a review for staff who already vaccinate adults; IAC Guide available for free download
In late 2017, the Immunization Action Coalition (IAC) announced the publication of its new book, Vaccinating Adults: A Step-by-Step Guide (Guide).
This completely updated guide on adult immunization (originally published in 2004) provides easy-to-use, practical information covering important “how-to” activities to help providers enhance their existing adult immunization services or introduce them into any clinical setting, including:
- setting up for vaccination services,
- storing and handling vaccines,
- deciding which people should receive which vaccines,
- administering vaccines,
- documenting vaccinations (including legal issues), and
- understanding financial considerations and billing information.
In addition, the Guide is filled with hundreds of web addresses and references to help providers stay up to date on the latest immunization information, both now and in the future.
The entire Guide is available to download/print free of charge at www.immunize.org/guide. The downloaded version is suitable for double-sided printing. Options are available online to download the entire book or selected chapters. The development of the Guide was supported by the National Vaccine Program Office (NVPO) and the Centers for Disease Control and Prevention (CDC). Expert staff from both agencies also provided early technical review of the content.
The Guide is a uniquely valuable resource to assist providers in increasing adult immunization rates. Be sure to get a copy today!
Related Links
Back to top
JOURNAL ARTICLES AND NEWSLETTERS
September issue of CDC's Immunization Works newsletter now available
CDC recently released the September issue of its monthly newsletter Immunization Works. The newsletter offers the immunization community information about current topics. The information is in the public domain and can be reproduced and circulated widely.
Related Links
Back to top
The Lancet Public Health publishes study projecting elimination of cervical cancer in Australia within two decades because of government program to vaccinate children against HPV
A study published by The Lancet Public Health projects elimination of cervical cancer in Australia within two decades because of the government program to vaccinate children against HPV. This study, The projected timeframe until cervical cancer elimination in Australia: a modelling study, by M.T. Hall, et al, was published on October 2. The Background section of the Summary is reprinted below.
In 2007, Australia was one of the first countries to introduce a national human papillomavirus (HPV) vaccination programme, and it has since achieved high vaccination coverage across both sexes. In December, 2017, organised cervical screening in Australia transitioned from cytology-based screening every 2 years for women aged from 18–20 years to 69 years, to primary HPV testing every 5 years for women aged 25–69 years and exit testing for women aged 70–74 years. We aimed to identify the earliest years in which the annual age-standardised incidence of cervical cancer in Australia (which is currently seven cases per 100,000 women) could decrease below two annual thresholds that could be considered to be potential elimination thresholds: a rare cancer threshold (six new cases per 100,000 women) or a lower threshold (four new cases per 100,000 women), since Australia is likely to be one of the first countries to reach these benchmarks.
Access the complete article: The projected timeframe until cervical cancer elimination in Australia: a modelling study (PDF)
Related Link
New York Times: In Australia, Cervical Cancer Could Soon Be Eliminated (11/3/18)
Back to top
EDUCATION AND TRAINING
NFID offers webinar on protecting adults with chronic health conditions against influenza on Thursday, October 11 (tomorrow)
The National Foundation for Infectious Diseases (NFID) will present a webinar titled Protecting Adults with Chronic Health Conditions against Influenza on October 11 at 12:00 p.m. (ET). NFID medical director William Schaffner, MD, will moderate the session that will include presentations by Margot Savoy, MD, MPH, Temple University School of Medicine, representing the American Academy of Family Physicians, and Allen J. Taylor, MD, MedStar Washington Hospital Center, representing the American College of Cardiology.
Back to top
National AHEC webinar on November 1 presents recommendations and tools for persuading parents that HPV vaccine is safe and effective
The National AHEC Organization will present a webinar titled "Since You Asked": Persuading Parents that HPV Vaccine is Safe and Effective in Practice" on November 1 at 3:00 p.m. (ET). The webinar presenters will be two pediatricians: Kristin Oliver, MD, MHS, Icahn School of Medicine, Mount Sinai, and Sharon G. Humiston, MD, MPH, FAAP, University of Missouri-Kansas City. The presenters will discuss practical approaches and highlight tools for persuading parents that HPV vaccine is safe and effective in a busy clinical setting.
Access information about the webinar and presenters.
Register for the webinar.
For additional information, email info@ntc.nationalahec.org.
Related Link
CONFERENCES AND MEETINGS
NFID Clinical Vaccinology Course scheduled for November 9–10 in Bethesda; submissions for poster presentations due by October 18
The National Foundation of Infectious Disease's (NFID) Fall 2018 Clinical Vaccinology Course will be held November 3–4 in Bethesda, MD. This 2-day course focuses on new developments and issues related to the use of vaccines. Expert faculty provide the latest information on vaccines, including updated recommendations for vaccinations across the lifespan, and innovative and practical strategies for ensuring timely and appropriate immunization. Continuing education credit is available for attendees.
NFID is inviting abstract submissions of original research and clinical practices for poster presentation. The deadline for submissions is October 18.
Related Links
Back to top
|
|
